share_log

Chardan Capital Reiterates Buy on Senti Biosciences, Maintains $6 Price Target

Chardan Capital Reiterates Buy on Senti Biosciences, Maintains $6 Price Target

Chardan Capital重申买入Senti Biosciences,维持6美元的目标股价
Benzinga ·  2023/08/15 04:25

Chardan Capital analyst Geulah Livshits reiterates Senti Biosciences (NASDAQ:SNTI) with a Buy and maintains $6 price target.

Chardan Capital分析师Geulah Livshits重申了Senti Biosciences(纳斯达克股票代码:SNTI)的买入,并维持6美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发